Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Darunavir, Etravirine, and Rilpivirine in Pregnant Women
NCT00855335Phase 3Completed
- Sponsor
- Janssen Scientific Affairs
- Start
- Apr 2009
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of darunavir, etravirine, rilpivirine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Janssen Scientific Affairs. Started Apr 2009; status: completed.
02
Drugs
darunaviretravirinerilpivirine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00855335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00855335.